Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Eshleman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|May 24, 2001
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)S H Eshleman, P Krogstad, J B Jackson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
Open Forum Infectious Diseases|January 16, 2025
Strong Association Between HIV Incidence and Herpes Simplex Virus Type 2 in Zambia and South Africa: Prospective Data From the HPTN 071 (PopART) TrialJ Bradley, S Floyd, E Piwowar-Manning, et al.
Health Policy and Planning|May 8, 2021
Community-based health workers implementing universal access to HIV testing and treatment: lessons from South Africa and Zambia-HPTN 071 (PopART)Lario Viljoen, Tila Mainga, Rozanne Casper, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|May 24, 2001
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)S H Eshleman, P Krogstad, J B Jackson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.
AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.
Open Forum Infectious Diseases|January 16, 2025
Strong Association Between HIV Incidence and Herpes Simplex Virus Type 2 in Zambia and South Africa: Prospective Data From the HPTN 071 (PopART) TrialJ Bradley, S Floyd, E Piwowar-Manning, et al.
Health Policy and Planning|May 8, 2021
Community-based health workers implementing universal access to HIV testing and treatment: lessons from South Africa and Zambia-HPTN 071 (PopART)Lario Viljoen, Tila Mainga, Rozanne Casper, et al.
Pageof 2